Isolating Immune Cells from Metastatic Melanoma
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Hinge Health, Center for Systems Biology, Genomics (United Kingdom), New York University, Dana-Farber Cancer Institute
Variable analysis
- None explicitly mentioned
- None explicitly mentioned
- Samples were coded with an anonymized 5-digit number and their identity was unknown to those performing the experiments
- PBMCs were re-suspended in human AB serum with 10% dimethyl sulfoxide, frozen at −80°C and stored in liquid nitrogen
- Cells were cultured with 10% AB human serum in beta-mercaptoethanol, non-essential amino acids, HEPES, penicillin, streptomycin and gentamicin supplemented X-VIVO media
- Serum was obtained from whole blood patient samples, centrifuged to remove cells and frozen at −80°C until time of use
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!